# OnCo record traverse-biotech (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/traverse-biotech/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "traverse-biotech" ;
  schema:name "Traverse Biotech"@en ;
  schema:alternateName "TRAVERSE BIOTECH II INC"@en, "Traverse Biotechnology"@en ;
  schema:description "Traverse Biotech is a New York company that licenses immunotherapies already tested outside the United States and develops them further. Its lead product, TB-Bs1, is an antibody that links T cells to cancer cells carrying the protein ROR2."@en ;
  schema:url <https://onco.cc/companies/traverse-biotech/>, <https://www.traversebiotech.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.traversebiotech.com/>, <https://www.traversebiotech.com/pipeline-4-1>, <https://reporter.nih.gov/project-details/11309753> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/tb-bs1/> .